Release Date: 30/04/09 17:34 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 208.07KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%